-
DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024
Mar 18, 2026, 21:38 PM -
ROBOTIC-ASSISTED PYELOPLASTY USING THE DA VINCI SURGICAL SYSTEMS COMPARED TO LAPAROSCOPIC OR OPEN APPROACH: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARATIVE OUTCOMES AND COSTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS IN TYPE 2 DIABETES PATIENTS WITH HEART FAILURE
Mar 18, 2026, 21:38 PM -
REAL-WORLD (RW) DISEASE PROGRESSION AND HEALTHCARE RESOURCE UTILIZATION (HCRU) AMONG PATIENTS WITH IGA NEPHROPATHY (IGAN) IN THE UNITED STATES (US)
Mar 18, 2026, 21:38 PM -
DISCREPANCIES BETWEEN GUIDELINE RECOMMENDATIONS AND REGULATORY APPROVALS IN MULTIPLE MYELOMA - IMPORTANCE OF EVIDENCE STRATIFICATION OF A LIVING SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
PREDICTING CHRONIC KIDNEY DISEASE IN PATIENTS WITH OBESITY: A PREDICTIVE MODELING APPROACH FOR PREVENTIVE CARE
Mar 18, 2026, 21:38 PM -
CAUSAL AI IN EPIDEMIOLOGY AND HEALTHCARE: CONCEPTS AND METHODOLOGIES
Mar 18, 2026, 21:38 PM -
A LIFETIME COST-UTILITY ANALYSIS OF IGLARLIXI VERSUS IDEGASP IN TYPE 2 DIABETES IN TURKIYE
Mar 18, 2026, 21:38 PM -
PRODUCTIVITY LOSSES AFTER MISCARRIAGE: A PROSPECTIVE COHORT ANALYSIS USING THE IMTA PRODUCTIVITY COST QUESTIONNAIRE
Mar 18, 2026, 21:38 PM -
TOLERABILITY PATIENT-REPORTED OUTCOMES IN FDA ONCOLOGY NEW DRUG APPROVALS (2021-2025)
Mar 18, 2026, 21:38 PM -
MULTIMODAL ASSESSMENT OF ICD-CODED SARCOPENIA DIAGNOSES IN THE REAL-WORLD SETTING
Mar 18, 2026, 21:38 PM -
ANALYSIS OF FDA REVIEW COMMENTS ON PATIENT-REPORTED OUTCOMES IN NEW DRUG APPLICATIONS(2021-2025)
Mar 18, 2026, 21:38 PM -
EXAMINING PATIENT AND TUMOR CHARACTERISTICS ASSOCIATED WITH THE RECEIPT OF NEOADJUVANT CHEMOTHERAPY (NAC) AMONG WOMEN WITH EARLY-STAGE HORMONE RECEPTOR-POSITIVE BREAST CANCER
Mar 18, 2026, 21:38 PM -
DEFINING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) IN REAL-WORLD RESEARCH: AN ANALYSIS OF CONCEPTUAL AND OPERATIONAL DEFINITION VARIABILITY
Mar 18, 2026, 21:38 PM -
PATTERNS AND TRENDS OF ANTIDIABETIC MEDICATION USE DURING PREGNANCY IN CHINA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION OF EU JOINT CLINICAL ASSESSMENT: AN EARLY LANDSCAPE OF SUBMISSION PATTERNS AND HTA INVOLVEMENT
Mar 18, 2026, 21:38 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Mar 18, 2026, 21:38 PM -
SHAREHOLDERS AND COMMON OWNERSHIP IN THE MARKET FOR MONOCLONAL ANTIBODIES: A NETWORK ANALYSIS
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR METABOLIC DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
FUNCTIONAL AND SOCIAL BURDEN OF SPINAL MUSCULAR ATROPHY TYPE 3 IN BRAZIL: A MIXED-METHODS PATIENT-CENTERED STUDY
Mar 18, 2026, 21:38 PM
